(SMG) Scotts Miracle-Gro - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8101861065
SMG EPS (Earnings per Share)
SMG Revenue
SMG: Lawn Care, Gardening, Hydroponic, Pest Control, Plant Food, Organic Products
The Scotts Miracle-Gro Company is a leading global player in the lawn, garden, and indoor gardening industries, operating through three primary segments: U.S. Consumer, Hawthorne, and Other. The company offers a diverse portfolio of products, including lawn fertilizers, grass seed, and gardening supplies, as well as hydroponic systems and indoor gardening solutions. With a presence in both the consumer and professional gardening markets, Scotts Miracle-Gro serves a wide range of customers, from home centers and mass merchandisers to independent hardware stores, nurseries, and e-commerce platforms.
Scotts Miracle-Gros product lineup is extensive, featuring well-known brands such as Scotts, Miracle-Gro, and Ortho, among others. The companys products cater to various gardening needs, including lawn care, gardening, and pest control. Additionally, its hydroponic and indoor gardening offerings, such as those under the General Hydroponics and AeroGarden brands, provide customers with innovative solutions for growing plants indoors. With a long history dating back to 1868, Scotts Miracle-Gro has established itself as a trusted name in the industry, with a strong distribution network and a significant online presence.
Analyzing the
Based on the analysis, a potential trading strategy could involve buying Scotts Miracle-Gros stock on dips to around 60, with a target price of 70-80 in the medium term. However, investors should closely monitor the companys future earnings reports and industry trends to adjust their strategies accordingly. Additionally, the negative RoE of -11.05 may indicate underlying issues with the companys profitability, which should be carefully considered when making investment decisions.
Additional Sources for SMG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
SMG Stock Overview
Market Cap in USD | 3,794m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 1992-01-31 |
SMG Stock Ratings
Growth Rating | -52.4 |
Fundamental | 22.0 |
Dividend Rating | 52.7 |
Rel. Strength | 4.96 |
Analysts | 4.36 of 5 |
Fair Price Momentum | 64.87 USD |
Fair Price DCF | 138.63 USD |
SMG Dividends
Dividend Yield 12m | 4.01% |
Yield on Cost 5y | 2.30% |
Annual Growth 5y | 1.92% |
Payout Consistency | 87.6% |
Payout Ratio | 85.4% |
SMG Growth Ratios
Growth Correlation 3m | 87.6% |
Growth Correlation 12m | -56% |
Growth Correlation 5y | -69.3% |
CAGR 5y | -10.53% |
CAGR/Max DD 5y | -0.13 |
Sharpe Ratio 12m | -0.28 |
Alpha | -0.66 |
Beta | 0.180 |
Volatility | 50.62% |
Current Volume | 558.3k |
Average Volume 20d | 856.7k |
As of July 01, 2025, the stock is trading at USD 65.96 with a total of 558,344 shares traded.
Over the past week, the price has changed by +3.89%, over one month by +15.09%, over three months by +21.49% and over the past year by +8.09%.
Neither. Based on ValueRay´s Fundamental Analyses, Scotts Miracle-Gro is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 21.98 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SMG is around 64.87 USD . This means that SMG is currently overvalued and has a potential downside of -1.65%.
Scotts Miracle-Gro has received a consensus analysts rating of 4.36. Therefor, it is recommend to buy SMG.
- Strong Buy: 7
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, SMG Scotts Miracle-Gro will be worth about 70.1 in July 2026. The stock is currently trading at 65.96. This means that the stock has a potential upside of +6.22%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 73 | 10.7% |
Analysts Target Price | 69.7 | 5.7% |
ValueRay Target Price | 70.1 | 6.2% |